Even specific DPP4 inhibitors have potential side effects (gastro-intestinal, cardiovascular, infective, inflammatory, and allergic events) due to their prolonging the action of a number of neuropeptides and chemokines as well as to their non-enzymatic functions.
Consistent with this postulate, we observed the greater increase in pSer-IRS-1 in women with stronger severity of depressive symptoms independently of use of psychotropic medications
In clinical trials, patients taking semaglutide GLP-1 over 68 weeks have been able to achieve weight loss of up to 10 to 20% of their total body weight
I was fortunate to have some very imprinting mentors early on, and one being Dr
You deserve progress that feels strong, sustainable, and rooted in health
Cross-trial inference can motivate a hypothesis